{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:15:26Z","timestamp":1787681726183,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-605","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T00:01:13Z","timestamp":1388102473000},"source":"Crossref","is-referenced-by-count":44,"title":["Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging Era of universal antiretroviral therapy use"],"prefix":"10.1186","volume":"13","author":[{"given":"Sadao","family":"Jinno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire C","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"2939_CR1","unstructured":"2011 CDC Sexually Transmitted Diseases Surveillance. \n                    http:\/\/www.cdc.gov\/std\/stats11\/syphilis.htm\n                    \n                  ,"},{"issue":"10","key":"2939_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1086\/644618","volume":"49","author":"JJ Gonzalez-Lopez","year":"2009","unstructured":"Gonzalez-Lopez JJ, Guerrero ML, Lujan R, Tostado SF, de Gorgolas M, Requena L: Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis. 2009, 49 (10): 1505-1511. 10.1086\/644618.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2939_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1258\/095646207782717018","volume":"18","author":"K Manavi","year":"2007","unstructured":"Manavi K, McMillan A: The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS. 2007, 18 (12): 814-818. 10.1258\/095646207782717018.","journal-title":"Int J STD AIDS"},{"issue":"10","key":"2939_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1086\/644737","volume":"49","author":"D Dowell","year":"2009","unstructured":"Dowell D, Polgreen PM, Beekmann SE, Workowski KA, Berman SM, Peterman TA: Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis. 2009, 49 (10): 1526-1529. 10.1086\/644737.","journal-title":"Clin Infect Dis"},{"issue":"RR-12","key":"2939_CR5","first-page":"1","volume":"59","author":"KA Workowski","year":"2010","unstructured":"Workowski KA, Berman S: Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2010, 59 (RR-12): 1-110.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"2939_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1086\/589295","volume":"47","author":"KG Ghanem","year":"2008","unstructured":"Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA: Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis. 2008, 47 (2): 258-265. 10.1086\/589295.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2939_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis757","volume":"55","author":"DF Knaute","year":"2012","unstructured":"Knaute DF, Graf N, Lautenschlager S, Weber R, Bosshard PP: Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis. 2012, 55 (12): 1615-1622. 10.1093\/cid\/cis757.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2939_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/cir671","volume":"53","author":"AC Sena","year":"2011","unstructured":"Sena AC, Wolff M, Martin DH, et al: Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis. Clin Infect Dis. 2011, 53 (11): 1092-1099. 10.1093\/cid\/cir671.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2939_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1086\/652239","volume":"201","author":"EW Hook 3rd","year":"2010","unstructured":"Hook EW, Behets F, Van Damme K, et al: A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis. 2010, 201 (11): 1729-1735. 10.1086\/652239.","journal-title":"J Infect Dis"},{"issue":"8","key":"2939_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00007435-200208000-00010","volume":"29","author":"EW Hook 3rd","year":"2002","unstructured":"Hook EW, Martin DH, Stephens J, Smith BS, Smith K: A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis. 2002, 29 (8): 486-490. 10.1097\/00007435-200208000-00010.","journal-title":"Sex Transm Dis"},{"issue":"12","key":"2939_CR11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJMoa044284","volume":"353","author":"G Riedner","year":"2005","unstructured":"Riedner G, Rusizoka M, Todd J, et al: Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005, 353 (12): 1236-1244. 10.1056\/NEJMoa044284.","journal-title":"N Engl J Med"},{"issue":"3","key":"2939_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/archneur.1971.00490030058006","volume":"25","author":"ME Raichle","year":"1971","unstructured":"Raichle ME, Kutt H, Louis S, McDowell F: Neurotoxicity of intravenously administered penicillin G. Arch Neurol. 1971, 25 (3): 232-239. 10.1001\/archneur.1971.00490030058006.","journal-title":"Arch Neurol"},{"issue":"16","key":"2939_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/BF01721921","volume":"59","author":"KA Neftel","year":"1981","unstructured":"Neftel KA, Walti M, Spengler H, et al: Neutropenia after penicillins: toxic or immune-mediated?. Klin Wochenschr. 1981, 59 (16): 877-888. 10.1007\/BF01721921.","journal-title":"Klin Wochenschr"},{"issue":"5","key":"2939_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199707313370504","volume":"337","author":"RT Rolfs","year":"1997","unstructured":"Rolfs RT, Joesoef MR, Hendershot EF, et al: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997, 337 (5): 307-314. 10.1056\/NEJM199707313370504.","journal-title":"N Engl J Med"},{"issue":"12","key":"2939_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/cid\/cit146","volume":"56","author":"J Dionne-Odom","year":"2013","unstructured":"Dionne-Odom J, Karita E, Kilembe W, et al: Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis. 2013, 56 (12): 1829-1837. 10.1093\/cid\/cit146.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2939_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MD.0b013e3181c2af86","volume":"88","author":"D Farhi","year":"2009","unstructured":"Farhi D, Benhaddou N, Grange P, et al: Clinical and serologic baseline and follow-up features of syphilis according to HIV status in the post-HAART era. Medicine (Baltimore). 2009, 88 (6): 331-340. 10.1097\/MD.0b013e3181c2af86.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2939_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/0003-4819-118-5-199303010-00005","volume":"118","author":"MN Gourevitch","year":"1993","unstructured":"Gourevitch MN, Selwyn PA, Davenny K, et al: Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med. 1993, 118 (5): 350-355. 10.7326\/0003-4819-118-5-199303010-00005.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2939_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.7326\/0003-4819-121-2-199407150-00003","volume":"121","author":"CM Hutchinson","year":"1994","unstructured":"Hutchinson CM, Hook EW, Shepherd M, Verley J, Rompalo AM: Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med. 1994, 121 (2): 94-100. 10.7326\/0003-4819-121-2-199407150-00003.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2939_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000018149","volume":"198","author":"M Janier","year":"1999","unstructured":"Janier M, Chastang C, Spindler E, et al: A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology. 1999, 198 (4): 362-369. 10.1159\/000018149.","journal-title":"Dermatology"},{"issue":"6","key":"2939_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1365-2958.1995.tb02288.x","volume":"15","author":"DL Cox","year":"1995","unstructured":"Cox DL, Akins DR, Porcella SF, Norgard MV, Radolf JD: Treponema pallidum in gel microdroplets: a novel strategy for investigation of treponemal molecular architecture. Mol Microbiol. 1995, 15 (6): 1151-1164. 10.1111\/j.1365-2958.1995.tb02288.x.","journal-title":"Mol Microbiol"},{"issue":"1","key":"2939_CR21","first-page":"1","volume":"32","author":"HJ Magnuson","year":"1948","unstructured":"Magnuson HJ, Eagle H, Fleischman R: The minimal infectious inoculum of Spirochaeta pallida (Nichols strain) and a consideration of its rate of multiplication in vivo. Am J Syph Gonorrhea Vener Dis. 1948, 32 (1): 1-18.","journal-title":"Am J Syph Gonorrhea Vener Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-605.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-605\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-605.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T12:45:26Z","timestamp":1548247526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2939"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-605","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"605"}}